Abstract
The neurotransmitter/neuromodulator dopamine plays an important role in both the central nervous system and the periphery. In the hypothalamopituitary system its function is a dominant and tonic inhibitory regulation of pituitary hormone secretion including prolactin-and proopiomelanocortin-derived hormones. It is well known that dopamine agonists, such as bromocriptine, pergolide, quinagolide, cabergoline, and lisuride, can inhibit PRL secretion by binding to the D2 dopamine receptors located on normal as well as tumorous pituitary cells. Moreover, they can effectively decrease excessive PRL secretion as well as the size of the tumor in patients having prolactinoma. Furthermore, dopamine agonists can also be used in other pituitary tumors. The major requirement for its use is that the tumor cells should express D2 receptors. Therefore, in addition to prolactinomas, targets of dopamine agonist therapy are somatotroph tumors, nonfunctioning pituitary tumors, corticotroph pituitary tumors, Nelson’s syndrome, gonadotropinomas, and thyrotropin-secreting pituitary tumors. It is also an option for the treatment of pituitary disease during pregnancy. Differences between the effectiveness and the resistance of different dopaminergic agents as well as the future perspectives of them in the therapy of pituitary tumors are discussed.
Similar content being viewed by others
References
Abs, R., Verhelst, J., Maiter, D., et al. (1998). J. Clin. Endocrinol. Metab. 83, 374–378.
Arita, J., Hashi, A., Hoshi, K., Mazawa, S., and Suzuki, S. (1998). Neuroendocrinology 68, 163–171.
Asa, S. L., Kelly, M. A., Grandy, D. K., and Low, M. J. (1999). Endocrinology 140, 5348–5355.
Autelitano, D. J., Snyder, L., Sealfon, S. C., and Roberts, J. L. (1989). Mol. Cell. Endocrinol. 67, 101–105.
Bankowski, B. J. and Zacur, H. A. (2003). Clin. Obstet. Gynecol. 46, 349–362.
Barlier, A., Pellegrini-Bouiller, I., Caccavelli, L., et al. (1997). Horm. Res. 47, 227–234.
Bell, P. M., Atkinson, A. B., Hadden, D. R., et al. (1986). Arch. Intern. Med. 146, 1145–1149.
Besser, G. M. and Wass, J. A. (1978). Med. J. Aust. 2, 31–33.
Bevan, J. S., Webster, J., Burke, C. W., and Scanlon, M. F. (1992). Endocr. Rev. 13, 220–240.
Biller, B. M. and Daniels, G. (1998). In: Harrison’s principles of internal medicine. Fauci, A. S., Braunwald, E., Isselbach, K., et al. (eds.). McGraw-Hill: New York.
Biller, B. M., Molitch, M. E., Vance, M. L., et al. (1996). J. Clin. Endocrinol. Metab. 81, 2338–2343.
Bunzow, J. R., Van Tol, H. H., Grandy, D. K., et al. (1988). Nature 336, 783–787.
Burrow, G. N., Wortzman, G., Rewcastle, N. B., Holgate, R. C., and Kovacs, K. (1981). N. Engl. J. Med. 304, 156–158.
Caron, M. G., Amlaiky, N., and Kilpatrick, B. F. (1986). In: Frontiers in neuroendocrinology. Ganong, W. F. and Martini, L. (eds.). Raven Press: New York.
Casulari, L. A., Naves, L. A., Mello, P. A., Pereira Neto, A., and Papadia, C. (2004). Horm. Res. 62, 300–305.
Ciccarelli, E. and Camanni, F. (1996). Drugs 51, 954–965.
Civelli, O., Bunzow, J. R., Grandy, D. K., Zhou, Q. Y., and Van Tol, H. H. (1991). Eur. J. Pharmacol. 207, 277–286.
Colao, A., Di Sarno, A., Cappabianca, P., Di Somma, C., Pivonello, R., and Lombardi, G. (2003). N. Engl. J. Med. 349, 2023–2033.
Colao, A., Di Sarno, A., Sarnacchiaro, F., et al. (1997). J. Clin. Endocrinol. Metab. 82, 876–883.
Colao, A., Ferone, D., Lastoria, S., et al. (2000). Clin. Endocrinol. 52, 437–445.
Colao, A., Loche, S., Cappa, M., et al. (1998). J. Clin. Endocrinol. Metab. 83, 2777–2780.
Colao, A. and Lombardi, G. (1997). J. Clin. Endocrinol. Metab. 82, 2755–2756.
Colao, A., Merola, B., Sarnacchiaro, F., et al. (1995). Horm. Res. 44, 222–228.
Colao, A., Vitale, G., Cappabianca, P., et al. (2004). J. Clin. Endocrinol. Metab. 89, 1704–1711.
Corenblum, B. and Donovan, L. (1993). Fertil. Steril. 59, 671–673.
Cozzi, R., Attanasio, R., Lodrini, S., and Lasio, G. (2004). Clin. Endocrinol. 61, 209–215.
Deleu, D., Northway, M. G., and Hanssens, Y. (2002). Clin. Pharmacokinet. 41, 261–309.
Di Sarno, A., Landi, M. L., Cappabianca, P., et al. (2001). J. Clin. Endocrinol. Metab. 86, 5256–5261.
Ezzat, S., Asa, S. L., Couldwell, W. T., et al. (2004). Cancer 101, 613–619.
Fahy, U. M., Foster, P. A., Torode, H. W., Hartog, M., and Hull, M. G. (1992). Gynecol. Endocrinol. 6, 183–188.
Freda, P. U., Andreadis, C. I., Khandji, A. G., et al. (2000). J. Clin. Endocrinol. Metab. 85, 8–13.
Freda, P. U. and Wardlaw, S. L. (1999). J. Clin. Endocrinol. Metab. 84, 3859–3866.
Freeman, M. E., Kanyicska, B., Lerant, A., and Nagy, G. M. (2000). Physiol. Rev. 80, 1523–1631.
Frieze, T. W., Mong, D. P., and Koops, M. K. (2002). Endocr. Pract. 8, 296–303.
Gillam, M. P., Middler, S., Freed, D. J., and Molitch, M. E. (2002). J. Clin. Endocrinol. Metab. 87, 4447–4451.
Giros, B., Sokoloff, P., Martres, M. P., Riou, J. F., Emorine, L. J., and Schwartz, J. C. (1989). Nature 342, 923–926.
Glaz, E. (2001). In: Textbook of clinical endocrinology and metabolism. Leovey, A. (ed.). Medicina: Budapest.
Hall, W. A., Luciano, M. G., Doppman, J. L., Patronas, N. J., and Olsdfield, E. H. (1994). Ann. Intern. Med. 120, 817–820.
Jackson, D. M. and Westlind-Danielsson, A. (1994). Pharmacol. Ther. 64, 291–370.
Jaffe, C. A. and Barkan, A. L. (1992). Endocrinol. Metab. Clin. North Am. 21, 713–735.
Kelly, M. A., Rubinstein, M., Asa, S. L., et al. (1997). Neuron 19, 103–113.
Kletzky, O. A. and Vermesh, M. (1989). Fertil. Steril. 51, 269–272.
Korbonits, M., Morris, D. G., Nanzer, A., Kola, B., and Grossman, A. B. (2004). Front. Horm. Res. 32, 63–95.
Kovacs, K., Stefaneanu, L., Horvath, E., et al. (1991). Virchows Arch. A. Pathol. Anat. Histopathol. 418, 439–446.
Krieger, D. T. (1983). Endocr. Rev. 4, 22–43.
Lamberts, S. W., de Lange, S. A., and Stefanko, S. Z. (1982). J. Clin. Endocrinol. Metab. 54, 286–291.
Leslie, W. D., Abrams, D. N., Greenberg, C. R., and Hobson, D. (1996). J. Nucl. Med. 37, 1589–1591.
MacLeod, R. (1976). In: Frontiers in neuroendocrinology. Martini, L. and Ganong, W. F. (eds.). Raven Press: New York.
Melmed, S., Dowling, H., and Frohman, L. (1994). Am. J. Med. 97, 468–473.
Miller, J. W. and Crapo, L. (1993). Endocr. Rev. 14, 443–458.
Missale, C., Nash, S. R., Robinson, S. W., Jaber, M., and Caron, M. G. (1998). Physiol. Rev. 78, 189–225.
Monsma, F. J. Jr., McVittie, L. D., Gerfen, C. R., Mahan, L. C., and Sibley, D. R. (1989). Nature 342, 926–929.
Murata, Y., Ando, H., Nagasaka, T., et al. (2003). J. Clin. Endocrinol. Metab. 88, 1988–1993.
Oppizzi, G., Liuzzi, A., Chiodini, P., et al. (1984). J. Clin. Endocrinol. Metab. 58, 988–992.
Passos, V. Q., Souza, J. J., Musolino, N. R., and Bronstein, M. D. (2002). J. Clin. Endocrinol. Metab. 87, 3578–3582.
Pinzone, J. J., Katznelson, L., Danila, D. C., Pauler, D. K., Miller, C. S., and Klibanski, A. (2000). J. Clin. Endocrinol. Metab. 85, 3053–3057.
Pivonello, R., Ferone, D., de Herder, W. W., et al. (2004). J. Clin. Endocrinol. Metab. 89, 2452–2462.
Pivonello, R., Matrone, C., Filippella, M., et al. (2004). J. Clin. Endocrinol. Metab. 89, 1674–1683.
Saiardi, A., Bozzi, Y., Baik, J. H., and Borrelli, E. (1997). Neuron 19, 115–126.
Saveanu, A., Lavaque, E., Gunz, G., et al. (2002). J. Clin. Endocrinol. Metab. 87, 5545–5552.
Schlechte, J. A. (2003). N. Engl. J. Med. 349, 2035–2041.
Selbie, L. A., Hayes, G., and Shine, J. (1989). DNA 8, 683–689.
Serri, O., Chik, C. L., Ur, E., and Ezzat, S. (2003). Can. Med. Assoc. J. 169, 575–581.
Shimon, I. and Melmed, S. (1998). Ann. Intern. Med. 129, 472–483.
Snyder, L. A., Roberts, J. L., and Sealfon, S. C. (1991). Neurosci. Lett. 122, 37–40.
Thapar, K., Kovacs, K., Scheithauer, B. W., and Lloyd, R. V. (eds.) (2001). Diagnosis and management of pituitary tumors. Humana Press: New Jersey.
Toldy, E., Locsei, Z., Szabolcs, I., et al. (2003). Endocrine 22, 267–273.
Verhelst, J. and Abs, R. (2003). Treat. Endocrinol. 2, 23–32.
Verhelst, J., Abs, R., Maiter, D., et al. (1999). J. Clin. Endocrinol. Metab. 84, 2518–2522.
Webster, J., Piscitelli, G., Polli, A., Ferrari, C. I., Ismail, I., and Scanlon, M. F. (1994). N. Engl. J. Med. 331, 904–909.
Yamakita, N., Komaki, T., Murai, T., and Kawamura, S. (1999). Intern. Med. 38, 266–271.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iván, G., Szigeti-Csúcs, N., Oláh, M. et al. Treatment of pituitary tumors. Endocr 28, 101–110 (2005). https://doi.org/10.1385/ENDO:28:1:101
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:28:1:101